| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13725* | 2021 |
| Therapeutic nanoparticles and their targeted delivery applications AA Yetisgin, S Cetinel, M Zuvin, A Kosar, O Kutlu Molecules 25 (9), 2193, 2020 | 820 | 2020 |
| Autophagy as a molecular target for cancer treatment NM Kocaturk, Y Akkoc, C Kig, O Bayraktar, D Gozuacik, O Kutlu European Journal of Pharmaceutical Sciences 134, 116-137, 2019 | 360 | 2019 |
| Lipid droplets in health and disease G Onal, O Kutlu, D Gozuacik, SD Emre Lipids in health and disease 16 (1), 128, 2017 | 323 | 2017 |
| Cleavage of Atg3 protein by caspase-8 regulates autophagy during receptor-activated cell death O Oral, D Oz-Arslan, Z Itah, A Naghavi, R Deveci, S Karacali, D Gozuacik Apoptosis 17, 810-820, 2012 | 192 | 2012 |
| Niosomal drug delivery systems for ocular disease—Recent advances and future prospects S Durak, M Esmaeili Rad, A Alp Yetisgin, H Eda Sutova, O Kutlu, ... Nanomaterials 10 (6), 1191, 2020 | 149 | 2020 |
| Molecular Pathogenesis of Nonalcoholic Steatohepatitis-(NASH-) Related Hepatocellular Carcinoma O Kutlu, HN Kaleli, E Ozer Canadian Journal of Gastroenterology and Hepatology 2018, 2018 | 123 | 2018 |
| Guidelines for the use and interpretation of assays for monitoring autophagy 1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... vol. 17 Issue: no. 1 Pages: 1-382, 2021 | 110 | 2021 |
| Physiological and pathological significance of the molecular cross-talk between autophagy and apoptosis O Oral, Y Akkoc, O Bayraktar, D Gozuacik Universidad de Murcia. Departamento de Biología Celular e Histología, 2016 | 97 | 2016 |
| RACK1 is an interaction partner of ATG5 and a novel regulator of autophagy S Erbil, O Oral, G Mitou, C Kig, E Durmaz-Timucin, E Guven-Maiorov, ... Journal of Biological Chemistry 291 (32), 16753-16765, 2016 | 63 | 2016 |
| Inertial focusing of cancer cell lines in curvilinear microchannels A Ozbey, M Karimzadehkhouei, NM Kocaturk, SE Bilir, O Kutlu, ... Micro and Nano Engineering 2, 53-63, 2019 | 45 | 2019 |
| The effect of dysfunctional ubiquitin enzymes in the pathogenesis of most common diseases G Celebi, H Kesim, E Ozer, O Kutlu International journal of molecular sciences 21 (17), 6335, 2020 | 38 | 2020 |
| IBMPFD disease-causing mutant VCP/p97 proteins are targets of autophagic-lysosomal degradation O Bayraktar, O Oral, NM Kocaturk, Y Akkoc, K Eberhart, A Kosar, ... PloS one 11 (10), e0164864, 2016 | 38 | 2016 |
| Magnetofection of green fluorescent protein encoding DNA-bearing polyethyleneimine-coated superparamagnetic iron oxide nanoparticles to human breast cancer cells M Zuvin, E Kuruoglu, VO Kaya, O Unal, O Kutlu, H Yagci Acar, D Gozuacik, ... ACS omega 4 (7), 12366-12374, 2019 | 37 | 2019 |
| Review on lithotripsy and cavitation in urinary stone therapy M Ghorbani, O Oral, S Ekici, D Gozuacik, A Koşar IEEE reviews in biomedical engineering 9, 264-283, 2016 | 36 | 2016 |
| Bubbly cavitating flow generation and investigation of its erosional nature for biomedical applications A Koşar, M Şeşen, O Oral, Z Itah, D Gozuacik IEEE transactions on biomedical engineering 58 (5), 1337-1346, 2011 | 32 | 2011 |
| Synthesis, characterization, and biological properties of composites of hydroxyapatite and hexagonal boron nitride S Unal, N Ekren, AZ Sengil, FN Oktar, S Irmak, O Oral, YM Sahin, O Kilic, ... Journal of Biomedical Materials Research Part B: Applied Biomaterials 106 (6 …, 2018 | 31 | 2018 |
| Protein kinase C isozymes and autophagy during neurodegenerative disease progression HN Kaleli, E Ozer, VO Kaya, O Kutlu Cells 9 (3), 553, 2020 | 30 | 2020 |
| Production of the biomimetic small diameter blood vessels for cardiovascular tissue engineering MO Aydogdu, J Chou, E Altun, N Ekren, S Cakmak, M Eroglu, AA Osman, ... International Journal of Polymeric Materials and Polymeric Biomaterials 68 …, 2019 | 26 | 2019 |
| Hydrodynamic cavitation kills prostate cells and ablates benign prostatic hyperplasia tissue Z Itah, O Oral, OY Perk, M Sesen, E Demir, S Erbil, AI Dogan-Ekici, S Ekici, ... Experimental Biology and Medicine 238 (11), 1242-1250, 2013 | 26 | 2013 |
